All MicroPine Articles
-
685Latest Myopia NewsEyenovia Regains Rights to MicroPine Atropine Spray in U.S. and Canada
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
-
3.2KLatest Myopia NewsEyenovia, Arctic Vision to Develop and Commercialize MicroPine and MicroLine in Asia
August 11, 2020 NEW YORK and SHANGHAI, China — Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose...
-
2.5KLatest Myopia NewsEyenovia Launches Website to Help Parents Find Its CHAPERONE Study
August 11, 2020 Eyenovia, which in June enrolled its first patient in its Phase 3 CHAPERONE study of progressive myopia, this month...
-
13.8KClinicalTopical Low-Dose Atropine: A Global Perspective
June 24, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Chief Medical Editor, Review of Myopia Management The use of atropine to...
-
5.3KLatest Myopia NewsEyenovia Developing a Microdose Treatment for Delivering Atropine
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...